Study: Vitamin D receptor and its antiproliferative effect in human pulmonary arterial hypertension ... of pulmonary artery smooth muscle and endothelial cells. PAH often leads to thickening ...
Merck is ending a Phase 3 trial of Winrevair early so all PAH patients in HYPERION can start active treatment with the drug ...
4 个月
Medpage Today on MSNSGLT2 Inhibitors Tied to Better Outcomes in Pulmonary Arterial HypertensionBOSTON -- Sodium-glucose cotransporter-2 (SGLT2) inhibitors were linked to long-term reductions in mortality risk among ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果